Status:
UNKNOWN
A Phase II Trial of Intermediate Radiation Dose For Lymphoma
Lead Sponsor:
Sunnybrook Health Sciences Centre
Conditions:
Follicular Lymphoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine the optimal radiation dose fractionation regimen for low grade follicular lymphoma. It is hypothesized that the complete response rate with the use of 12 Gy ...
Eligibility Criteria
Inclusion
- ≥ 18 years or older
- Pathology review at Sunnybrook Health Sciences Centre showing low grade (grade 1- 2) follicular lymphoma
- Previously un-irradiated stages I-IV low grade follicular lymphoma
- Radiation indicated for local disease control (radical or palliative)
- Able to give informed consent
- Non-bulky targets (less than 7cm)
Exclusion
- Systemic therapy (including steroids) for lymphoma within 3 months before or after radiotherapy
- Prognosis less than 3 months
- Pregnancy
Key Trial Info
Start Date :
February 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT05284825
Start Date
February 28 2022
End Date
January 1 2025
Last Update
February 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5